Anumana uses AI and translational science to decode electrical signals from the heart, enabling healthcare providers to transform patient care throughout the cardiac clinical pathway. The company recently acquired NeuTrace and is leveraging the power of novel ECG-EGM-EMR integration for clinically valuable, actionable insights. Anumana's software products can be integrated into routine clinical practice for earlier disease diagnosis and in-procedure decision-making. The company aims to introduce a new standard of care in cardiac clinical care supported by reimbursement.